Avalo Therapeutics (AVTX) Stock Price, Quote, News & History | Benzinga

Avalo Therapeutics Inc (AVTX) Stock Price, Quote, News & History

AVTXNASDAQ

Trade with Public

Trade with Public

$15.75

-0.20-1.25%

At close: May 29, 5:00 PM EST

$15.75

-0.20-1.25%

Pre-Market: 5:14 AM EST

OverviewNews Earnings Events Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

-

Close

$15.75

Volume / Avg.

121.00 / 1.46M

Day Range

- - -

52 Wk Range

3.61 - 24.27

Market Cap

$827.91M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

44

Short Interest

11.92%

Days to Cover

1.59

Recent Avalo Therapeutics Inc News

These Analysts Revise Their Forecasts On Avalo Therapeutics After Q1 Results

Avalo Therapeutics reported better-than-expected Q1 loss due to positive trial results. Analysts maintain Buy ratings with lowered price targets.

Avi Kapoor

Avalo Therapeutics Stock Soars After Positive LOTUS Trial Results

Avalo Therapeutics Inc (NASDAQ:AVTX) shares are surging after the company delivered a major clinical win, strengthened its balance sheet with a new offering and picked up fresh support from Wall Street analysts.

Evette Mitkov

Avalo Therapeutics Stock Jumps 33% In Pre-Market Session: Here's Why

Avalo Therapeutics Inc. rises sharply in pre-market trading following a Phase 2 trial win and a $375 million offering.

Mohd Haider

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-59.69M

Investing Cash Flow (TTM)

-56.22M

Financing Cash Flow (TTM)

15.99M

Free Cash Flow (TTM)

-59.69M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-99.92M

Analyst Trends and Forecast

1

Feb

2

Mar

2

Apr

6

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$746.24M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

4218.55

PB Ratio (TTM)

12.12

Earnings Yield % (TTM)

-35.37%

Earnings Yield % (FWD)

-16.63%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.30

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$24.99M

Debt to Equity

0.00

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$15.75

Volume / Avg.

121.00 / 1.46M

Day Range

- - -

52 Wk Range

3.61 - 24.27

Market Cap

$827.91M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

44

Short Interest

11.92%

Days to Cover

1.59

About

Sector

Health Care

Industry

Biotechnology

Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), t...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Avalo Therapeutics (AVTX) stock?

A

You can purchase shares of Avalo Therapeutics (NASDAQ:AVTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Avalo Therapeutics (AVTX) competitors?

A

There are no as such competitors for Avalo Therapeutics.

Q

What is the forecast, or price target, for Avalo Therapeutics (AVTX) stock?

A

Avalo Therapeutics has a consensus price target of $38.05.

Q

What is the current price for Avalo Therapeutics (AVTX)?

A

The stock price for Avalo Therapeutics (NASDAQ: AVTX) is $15.75 last updated June 1, 2026 at 4:00 PM EDT.

Q

Does Avalo Therapeutics (AVTX) pay a dividend?

A

There are no upcoming dividends for Avalo Therapeutics.

Q

When is Avalo Therapeutics (NASDAQ:AVTX) reporting earnings?

A

Avalo Therapeutics does not have any upcoming earnings scheduled.

Q

Is Avalo Therapeutics (AVTX) going to split?

A

There is no upcoming split for Avalo Therapeutics.

Q

What sector and industry does Avalo Therapeutics (AVTX) operate in?

A

Avalo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.